)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Crescita Therapeutics
Crescita Therapeutics (CTX) investor relations material
Crescita Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary4 Nov, 2025
Executive summary
Q3-2025 revenue rose to $5,393, up $1,799 year-over-year, driven by strong Manufacturing segment performance and new client volumes.
Net income reached $753, reversing a net loss of $(1,036) in Q3-2024; adjusted EBITDA improved to $262 from $(681).
Acquisition of Laboratoire Provence-Canada Inc. assets and a new five-year supply agreement expanded recurring revenue and manufacturing capacity.
Financial highlights
Gross profit increased to $2,855 from $1,967 year-over-year; gross margin was 52.9% versus 54.7%.
Operating expenses decreased to $3,017 from $3,139; operating loss narrowed to $(162) from $(1,172).
Cash and cash equivalents ended at $8,308, up $124 for the quarter.
Cash provided by operating activities was $1,173 for the quarter.
Outlook and guidance
Integration of acquired assets and new supply agreement expected to bolster recurring revenue and plant utilization.
Management continues to seek new partnerships for Pliaglis in regained territories.
Manufacturing segment growth strategy
Pliaglis commercialization plan for regained territories
Future of TBY investment and contingent capital
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Crescita Therapeutics
- Growth driven by new contracts, acquisition, and a focus on recurring revenue and U.S. expansion.CTX
Planet MicroCap Showcase: VANCOUVER 202420 Jan 2026 - Revenue and profit fell in Q1-2025, but outlook anticipates recovery as orders are fulfilled.CTXQ1 20252 Oct 2025
- Revenue and profit surged in Q2-2025, aided by new contracts and a major licensing payment.CTXQ2 202519 Aug 2025
- Q2 revenue declined 21% as manufacturing sales dropped, but new deals and acquisitions target recovery.CTXQ2 202413 Jun 2025
- Q3-2024 revenue up 18.5% year-over-year, driven by Skincare and Licensing growth.CTXQ3 202413 Jun 2025
- Revenue up 12% to $19.6M, but net loss increased to $2.8M on higher costs.CTXQ4 20245 Jun 2025
Next Crescita Therapeutics earnings date
Q4 202518 Mar, 2026
Crescita Therapeutics
Next Crescita Therapeutics earnings date
Q4 202518 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage